Global CRISPR and Cas genes market was valued at US$ 1,451.6 Mn in 2017 and is anticipated to reach US$ 7,234.5 Mn by 2026, expanding at a CAGR of 20.1% from 2018 to 2026.
Transparency Market Research (TMR) has published a new report titled, “CRISPR and Cas Genes Market
- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the
report, the global CRISPR and Cas genes market was valued at US$ 7,234.5 Mn by 2026, expanding at a
CAGR of around 20.1% from 2018 to 2026.
Increase in applications of CRISPR and Cas gene editing technology in bacteria and usage of gene editing
technology for prevention of various diseases are the major factors anticipated to drive the market from
2018 to 2026. Rise in need of alternative medicine for chronic diseases and increase in investments by
key players in Asia Pacific are projected to propel the market during the forecast period.
Request a PDF Sample -
Increase in Usage of DNA-free Cas
DNA-free Cas9 is most commonly used with synthetic crRNA tracrRNA and chosen by researchers who
strive to avoid unwanted vector DNA integration into their genomic DNA. CRISPR-Cas9 utilizing mRNA or
protein is ideal for applications such as knocking of a fluorescent reporter using HDR or knockout cell
line generation. Advantages such as gene editing with DNA-free CRISPR-Cas9 components to reduce
potential off-targets and potential usage of CRISPR-Cas9 gene editing to find correlations with human
diseases in model systems drive the segment.
Rise in Incidence of Genetic Disorders and Increase in Applications of CRISPR and Cas Genes to Propel
Genetic diseases are generally termed as rare diseases. According to NCBI, prevalence of these rare
diseases is approximately 5 in 10,000. There are 6,000 to 8,000 rare diseases, with 250 to 280 new
diseases diagnosed every year. Hence, 6% to 8% of the global population is projected to be affected by
rare diseases i.e., genetic diseases in the near future. Researchers are developing treatments for these
diseases with applications of new technologies such as CRISPR. The applications of